Clinical outcomes of mesh exposure/extrusion: presentation, timing and management

Lo TS 1 , Tan YL 2 , Cortes EF 2 , Wu PY 1 , Pue LB 2 , Al-Kharabsheh A 2

Affiliations 

  • 1 Department of Obstetrics and Gynecology, Keelung and Taipei, Medical Center, Chang Gung Memorial Hospital, Keelung, Taiwan
  • 2 Fellow of the Division of Urogynecology, Department of Obstetrics and Gynecology, School of Medicine, Chang Gung Memorial Hospital, Chang Gung University, Taoyuan, Taiwan
Aust N Z J Obstet Gynaecol, 2015 Jun;55(3):284-90.
PMID: 26044791 DOI: 10.1111/ajo.12340

Abstract

The Food and Drug Administration has recently highlighted an increase in reported complications associated with the use of transvaginal mesh.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

MeSH terms
Similar publications